TG Therapeutics | Rentekostnader



Interest Expense On Debt Endring Dato
AbbVie USD 610M 19M 2024-12
Alaunos Therapeutics USD 0 0 2023-12
Amgen USD 747M 29M 2024-12
Ardelyx USD 3.97M 610K 2024-12
Arrowhead Research USD 21.65M 7M 2024-12
Bayer 703M 61M 2024-12
Biogen USD 60M 200K 2024-12
Corcept Therapeutics 6M 6M 2024-06
Dynavax Technologies USD 1.7M 5K 2024-12
Gilead Sciences USD 260M 12M 2025-03
J&J USD 128M 9M 2025-03
Novartis USD 275M 11M 2024-12
PTC Therapeutics USD 43.35M 1.24M 2024-12
Regeneron Pharmaceuticals USD 10.5M 3.3M 2024-12
Roche Holding CHF 311.5M 1000K 2024-12
TG Therapeutics USD 10.83M 6.86M 2024-09
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12



TG Therapeutics Rentekostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.